Real-time enrollment status for this mds (myelodysplastic syndrome) clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 9:24 AM UTC
| NCT Number | NCT07096297 |
| Recruiting Status | Recruiting |
| Condition | MDS (Myelodysplastic Syndrome) |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Yale University |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 17, 2026: Clinical trial NCT07096297 is currently recruiting participants. This phase2 study for mds (myelodysplastic syndrome) is actively seeking new participants at 4 locations across the United States. The study is sponsored by Yale University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07096297 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07096297 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.